Taysha Gene Therapies Inc...

NASDAQ: TSHA · Real-Time Price · USD
2.92
-0.02 (-0.68%)
At close: Aug 15, 2025, 3:59 PM
2.98
1.88%
After-hours: Aug 15, 2025, 07:17 PM EDT

Taysha Gene Therapies Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
139.04M 143.94M 87.88M 149.1M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
2.15M 2.15M 2.64M 2.64M
Other Long-Term Assets
217K 304K 3.95M 1.11M
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
892K 4.83M 6.03M 6.63M
Total Current Assets
142.13M 149.87M 96.42M 159.6M
Property-Plant & Equipment
15.87M 20.41M 25.91M 50.61M
Goodwill & Intangibles
n/a n/a -4.99M n/a
Total Long-Term Assets
18.23M 22.86M 29.86M 54.35M
Total Assets
160.36M 172.73M 126.28M 213.96M
Account Payables
3.59M 6.37M 10.95M 21.76M
Deferred Revenue
9.77M 18.11M 33.56M n/a
Short-Term Debt
2.27M 1.65M 1.52M n/a
Other Current Liabilities
4.16M 5.57M 12.73M 4.13M
Total Current Liabilities
26.23M 36.76M 62.79M 51.75M
Long-Term Debt
43.94M 40.51M 37.97M 37.19M
Other Long-Term Liabilities
930K 1.58M 4.13M 3.73M
Total Long-Term Liabilities
62.61M 61.04M 62.54M 66.83M
Total Liabilities
88.84M 97.79M 125.33M 118.57M
Total Debt
63.18M 61.11M 59.93M 63.09M
Common Stock
2K 2K 1K n/a
Retained Earnings
-602.3M -513.01M -401.44M -235.65M
Comprehensive Income
-4.03M n/a n/a n/a
Shareholders Equity
71.53M 74.94M 949K 95.38M
Total Investments
2.15M 2.15M 2.64M 2.64M